Lihat di Bahasa Lain

Prima Biomed Ltd

ASX:PRR ISIN:AU000000PRR9

Prima Biomed (ASX:PRR) is a biotechnology company based in Sydney, Australia. The Company is focused on technologies in the fields of immunology and cancer immunotherapy. Prima is focused on developing a dendritic-cell based immunotherapy targeting mucin-1 tumour expressed antigen. Prima's lead product, CVac(tm) has completed Phase IIa clinical development in Ovarian Cancer and is working to a path of US FDA IND approval.

  

Berita

Laporan Pasar Australia 21 Februari 2011: Prima BioMed (ASX:PRR) Tengah Memulai Uji Klinis Untuk Vaksin Imunoterapi Kanker Ovarian

🕔2/21/2011 2:13:54 PM 22713

Laporan Pasar Australia 21 Februari 2011 memuat: Prima BioMed (ASX:PRR) akan memulai Tahap III uji coba klinis bagi vaksin imunoterapi kanker; Redstone Resources Limited (ASX:RDS) mengumumkan hasil tembaga bermutu tinggi di Proyek Tembaga Tollu di Australia Barat; Western Desert Resources Limited (ASX:WDR) melaporkan hasil biji besi bermutu tinggi di Proyek Biji Besi Roper Bar di Northern Territory; Canyon Resources Limited (ASX:CAY) memperbaharui percepatan program penggalian di Burkina Faso.

Baca Full Story
###

67,827 TAMPILAN PROFIL PERUSAHAAN

  • Halaman ini dilihat: (7 Hari Terakhir: 18) (30 Hari Terakhir: 54) (Sejak Ditampilkan: 8201) 

Pasar ASX:PRR

Data Perusahaan

    Markas Besar
  • Suite 1705, 109 Pitt St
    Sydney NSW 2000 AUSTRALIA
  • Telepon
  • +61 2 9232 4420 
  • Fax
  • +61 2 9232 4450 
  • Sektor Utama
  • Kesehatan & Pharm 
  • Industri Utama
  • Biotechnology 
  • Homepage
  • www.primabiomed.com.au

Media sosial